Physician
Dermatology
Dr. Louis D. Falo Jr., MD
|
|
Give Review
Doctor Louis D. Falo Jr., MD works in the field of Dermatology. He graduated from Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School has a rank of 1 in research and a 12 in primary care He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Elected Member". Louis Falo has written publications. He has 76 publications published with PubMed. The lastest paper is: 'A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.'
Publications
- Novel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma.
- "Toll"-erance in the Skin.
- Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreading.
- Dissolvable Microneedle Arrays for Intradermal Delivery of Biologics: Fabrication and Application.
- Signaling through Purinergic Receptors for ATP Induces Human Cutaneous Innate and Adaptive Th17 Responses: Implications in the Pathogenesis of Psoriasis.
- Human Beta-Defensin 3 Induces Maturation of Human Langerhans Cell-Like Dendritic Cells: An Antimicrobial Peptide that Functions as an Endogenous Adjuvant.
- Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type-1 immunity by licensing host dendritic cells to produce IL-12.
- Genetic Targeting of the Active Transcription Factor XBP1s to Dendritic Cells Potentiates Vaccine-induced Prophylactic and Therapeutic Antitumor Immunity.
- Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity.
- IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors.
- Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligation.
- Tumor regulatory T cells potently abrogate antitumor immunity.
- Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells.
- Acitretin for treatment of EGFR inhibitor-induced cutaneous toxic effects.
- Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity.
- A 'good death' for tumor immunology.
- Phagocytosis induces lysosome remodeling and regulated presentation of particulate antigens by activated dendritic cells.
- Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.
- Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector.
- CD4+ T cell responses elicited by different subsets of human Skin migratory dendritic cells.
- Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine.
- Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
- Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer.
- Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
- Changing paradigms in cutaneous immunology: adapting with dendritic cells.
- Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells.
- Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation.
- Lipid-protamine-DNA-mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses.
- Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production.
- Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS.
- Skin Immunization Obviates Alcohol-Related Immune Dysfunction.
- Role of infectious agents in cutaneous T-cell lymphoma: facts and controversies.
- Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor ...
- Systemic administration of naked DNA encoding interleukin 12 for the treatment of human papillomavirus DNA-positive tumor.
- Olmsted syndrome. Case report and identification of a keratin abnormality.
- Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.
- Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells.
- DNA immunisation: altering the cellular localisation of expressed protein and the immunisation route allows manipulation of the immune response.
- Dermal-resident CD14+ cells differentiate into Langerhans cells.
- Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo.
- Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation.
- Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells.
- Direct transfection and activation of human cutaneous dendritic cells.
- Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein.
- Generating and regulating immune responses through cutaneous gene delivery.
- Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway.
- Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo.
- Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines.
- Targeting the Skin for genetic immunization.
- A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
- Giving DNA vaccines a helping hand.
- DNA immunization targeting the Skin: molecular control of adaptive immunity.
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
- Evolution of a naevus spilus.
- Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity.
- Expression and function of the costimulatory molecule B7 on murine Langerhans cells: evidence for an alternative CTLA-4 ligand.
- Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity.
- Cerulenin is a potent inhibitor of antigen processing by antigen-presenting cells.
- Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific Ia-restricted, but not allospecific, stimulation of ...
- Characterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases.
- Effects of in vivo monoclonal anti-I-A antibody treatment in neonatal mice on intrathymic and peripheral class II antigen expression.
- Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes.
- Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.
- Cytotoxic T cells in basal cell carcinomas of Skin.
- Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection.
- Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity.
- DNA-based immunization by in vivo transfection of dendritic cells.
- Treatment of pyogenic granulomas with the 585 nm pulsed dye laser.
- ''Survival gene'' Bcl-xl potentiates DNA-raised antitumor immunity.
- Immunostimulation of dendritic cells by cationic liposomes.
- Lentivirus as a potent and mechanistically distinct vector for genetic immunization.
- Transcriptional IL-15-directed in vivo DC targeting DNA vaccine.
- The immunology of DNA vaccines.
- Novel approach to gene expression profiling in Sézary syndrome.
- Recombinant lentivector as a genetic immunization vehicle for antitumor immunity.
Schools
Harvard Medical School
Mass Gen Hospital
Conditions Treated
- Dermatitis
- Hives
- Itchy Skin
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
UPMC Presbyterian Shadyside
Helpful Reviews
Similar Doctors
|
|
Dr. Judith A. Small, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie E. Costa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James B. Bridenstine, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brendan B. Pillemer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. McSorley III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan L. Safyan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peggy L. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan W. Solter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen A. Stephen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evelyn J. Cheung, MD |
|
|
Ryan J. Harris |